Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303 Patients correctly think of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback